2020年云南省昆明市肿瘤登记地区恶性肿瘤发病和死亡特征及2016—2020年趋势分析

doi:10.11904/j.issn.1002-3070.2025.03.001

实用肿瘤学杂志 ›› 2025, Vol. 39 ›› Issue (3): 169-176.doi: 10.11904/j.issn.1002-3070.2025.03.001

• 癌情监测 • 下一篇

2020年云南省昆明市肿瘤登记地区恶性肿瘤发病和死亡特征及2016—2020年趋势分析

李吉¹, 张茂镕¹, 杨昭¹, 文洪梅², 伍福仙², 李云涛¹

1.昆明市疾病预防控制中心慢病科(昆明 650034);
2.云南省疾病预防控制中心慢病所

收稿日期:2025-02-18 修回日期:2025-04-20 出版日期:2025-06-28 发布日期:2025-07-02
通讯作者: 李吉,E-mail:ynkml96@outlook.com
作者简介:李吉,女,(1989—),硕士,主治医师,从事肿瘤流行病学的研究。
基金资助:
中国医学科学院医学与健康科技创新工程重大协同创新项目(编号:2021-I2M-1-011)

Analyses for the incidence and mortality characteristics of malignant tumors in the cancer registration areas of Kunming City,Yunnan Province in 2020 and their trend from 2016 to 2020

LI Ji¹, ZHANG Maorong¹, YANG Zhao¹, WEN Hongmei², WU Fuxian², LI Yuntao¹

1. Department of Non-communicable Disease Control and Prevention,Kunming Center for Disease Control and Prevention,Kunming 650034,China;
2. Institute of Non-communicable Disease Control and Prevention,Yunnan Center for Disease Control and Prevention

Received:2025-02-18 Revised:2025-04-20 Online:2025-06-28 Published:2025-07-02

摘要/Abstract

摘要： 目的分析昆明市肿瘤登记地区2020年恶性肿瘤发病和死亡情况及2016—2020年变化趋势。方法利用2020年昆明市符合质量控制要求的12个肿瘤登记地区的恶性肿瘤数据,分析不同性别和地区恶性肿瘤的粗发病率、粗死亡率、中标发病率和中标死亡率。应用Joinpoint 5.3.0.0软件计算年度变化百分比(annual percentage change,APC),评价2016—2020年恶性肿瘤发病和死亡趋势。结果 2020年昆明市肿瘤登记地区恶性肿瘤的粗发病率、中标发病率分别是234.27/10万和141.68/10万,中标发病率男性高于女性(146.94/10万 vs. 137.33/10万,Z=3.459,P＜0.001),农村地区高于城市地区(146.37/10万 vs. 134.09/10万,Z=-4.462,P＜0.001)。恶性肿瘤粗死亡率、中标死亡率分别是135.67/10万和73.18/10万,中标死亡率男性高于女性(91.65/10万 vs. 55.43/10万,Z=19.260,P＜0.001),农村地区高于城市地区(76.27/10万 vs. 70.00/10万,Z=-3.359,P＜0.001)。恶性肿瘤81.39%的新发病例、90.36%的死亡病例发生在50岁以上人群。昆明市肿瘤登记地区发病前5位的恶性肿瘤分别是肺癌、结直肠癌、乳腺癌、肝癌和前列腺癌。昆明市肿瘤登记地区死亡前5位的恶性肿瘤分别为肺癌、肝癌、结直肠癌、前列腺癌和胃癌。2016—2020年,昆明市城市肿瘤登记地区恶性肿瘤中标发病率(APC=-3.05%,95% CI:-5.91%~-0.10%,P=0.046)和中标死亡率(APC=-5.47%,95% CI:-8.52%~-2.32%,P=0.012)均呈现下降趋势。结论 2016—2020年昆明市城市肿瘤登记地区恶性肿瘤中标发病率和中标死亡率呈下降趋势,但在农村肿瘤登记地区没有明显变化趋势。农村地区是昆明市恶性肿瘤防治的重点地区;肺癌、结直肠癌、肝癌和前列腺癌是防治的重点癌种。

关键词: 恶性肿瘤, 发病率, 死亡率, 趋势分析, 昆明市

Abstract: Objective The aim of this study was to analysis the incidence and mortality of malignant tumors in the cancer registration area of Kunming City in 2020,as well as the trend of changes from 2016 to 2020. Methods The malignant tumor data of 12 cancer registration areas in Kunming in 2020 that met the quality criteria were used to analyze the crude incidence,crude mortality,age-standardized incidence/mortality rate by Chinese standard population(ASIRC/ASMRC)of malignant tumors in different genders and regions.The annual percentage change(APC)was calculated using Joinpoint 5.3.0.0 software,the incidence and mortality trends of malignant tumors from 2016 to 2020 were evaluated. Results In 2020,the crude incidence and ASIRC of malignant tumors in cancer registration areas of Kunming City were 234.27/100,000 and 141.68/100,000,respectively.The ASIRC of males was higher than that of females(146.94/100,000 vs. 137.33/100,000,Z=3.459,P＜0.001),and that of rural areas was higher than that of urban areas(146.37/100,000 vs. 134.09/100,000,Z=-4.462,P＜0.001).The crude mortality and ASMRC of malignant tumors were 135.67/100,000 and 73.18/100,000,respectively.The ASMRC of males was higher than that of females(91.65/100,000 vs. 55.43/100,000,Z=19.260,P＜0.001),and that of rural areas was higher than that of urban areas(76.27/100,000 vs. 70.00/100,000,Z=-3.359,P＜0.001).There were 81.39% of new cases and 90.36% of deaths of malignant tumors occurred in the population aged 50 and above.The top 5 cancer incidence in the Kunming City were lung cancer,colorectal cancer,breast cancer,liver cancer and prostate cancer.The top 5 cancer mortality were lung cancer,liver cancer,colorectal cancer,prostate cancer and stomach cancer.The ASIRC(APC=-3.05%,95% CI:-5.91%-0.10%,P=0.046)and ASMRC(APC=-5.47%,95% CI:-8.52%-2.32%,P=0.012)of malignant tumors in urban areas of Kunming showed a downward trend. Conclusions From 2016 to 2020,the ASIRC and ASMRC of malignant tumors in urban areas of Kunming showed a downward trend,but there was no significant changing trend in rural tumor registration areas.Rural areas are key areas for the prevention and treatment of malignant tumors in Kunming city;Lung cancer,colorectum cancer,liver cancer and prostate cancer are the key types of cancer for prevention and treatment.

Key words: Malignant tumors, Incidence, Mortality, Trend analysis, Kunming City

中图分类号:

R73-31

李吉, 张茂镕, 杨昭, 文洪梅, 伍福仙, 李云涛. 2020年云南省昆明市肿瘤登记地区恶性肿瘤发病和死亡特征及2016—2020年趋势分析[J]. 实用肿瘤学杂志, 2025, 39(3): 169-176.

LI Ji, ZHANG Maorong, YANG Zhao, WEN Hongmei, WU Fuxian, LI Yuntao. Analyses for the incidence and mortality characteristics of malignant tumors in the cancer registration areas of Kunming City,Yunnan Province in 2020 and their trend from 2016 to 2020[J]. Journal of Practical Oncology, 2025, 39(3): 169-176.

参考文献

1 中国疾病预防控制中心慢性非传染性疾病预防控制中心,国家卫生健康委统计信息中心.中国死因监测数据集.2020[M].北京:中国科学技术出版社,2021:27-28.
2 Han B,Zheng R,Zeng H,et al.Cancer incidence and mortality in China,2022[J].J Natl Cancer Cent,2024,4(1):47-53.
3 Bray F,Parkin DM.Evaluation of data quality in the cancer registry:principles and methods.Part I:comparability,validity and timeliness[J].Eur J Cancer,2009,45(5):747-755.
4 国家癌症中心.2022中国肿瘤登记年报[M].北京:人民卫生出版社,2025:78-83.
5 陈茂森,陈杨,石青萍,等.2020年云南省恶性肿瘤发病和死亡分析[J].实用肿瘤学杂志,2024,38(5):283-288.
6 钟女娟,马晶昱,许志达.2019年福建省福清市恶性肿瘤发病与死亡情况及2015—2019年趋势分析[J].实用肿瘤学杂志,2024,38(1):1-6.
7 Ju W,Zheng R,Zhang S,et al.Cancer statistics in Chinese older people,2022:current burden,time trends,and comparisons with the US,Japan,and the Republic of Korea[J].Sci China Life Sci,2023,66(5):1079-1091.
8 袁芝佩,王丹,成姝雯,等.2019年四川省肿瘤登记地区恶性肿瘤发病与死亡及2015—2019年变化趋势分析[J].中国肿瘤,2024,33(7):515-522.
9 Feng R,Su Q,Huang X,et al.Cancer situation in China:what does the China cancer map indicate from the first national death survey to the latest cancer registration?[J].Cancer Commun(Lond),2023,43(1):75-86.
10 Qiu H,Cao S,Xu R.Cancer incidence,mortality,and burden in China:a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020[J].Cancer Commun(Lond),2021,41(10):1037-1048.
11 陈红雨,秦明芳,杨永芳,等.云南省成年居民慢性病危险因素流行情况及聚类特征分析[J].中国慢性病预防与控制,2022,30(11):806-810.
12 刘毅,陈平,张寒蕾,等.云南省成人媒体控烟信息及烟草广告暴露状况调查[J].健康教育与健康促进,2023,18(5):454-457.
13 Cao M,Li H,Sun D,et al.Cancer screening in China:The current status,challenges,and suggestions[J].Cancer Lett,2021,506:120-127.
14 Bretthauer M,Loberg M,Wieszczy P,et al.Effect of colonoscopy screening on risks of colorectal cancer and related death[J].N Engl J Med,2022,387(17):1547-1556.
15 师金,梁迪,李道娟,等.中国城市癌症早诊早治项目筛查依从性及影响因素研究[J].中国肿瘤,2021,30(8):591-599.
16 Ilic D,Djulbegovic M,Jung JH,et al.Prostate cancer screening with prostate-specific antigen(PSA)test:a systematic review and meta-analysis[J].BMJ,2018,362:k3519.
17 李纪宾,王宝华,邹小农,等.前列腺癌的筛查策略现状及中国前列腺癌筛查专家共识[J].中国肿瘤临床与康复,2024,31(4):201-217.
18 Shaukat A,Levin TR.Current and future colorectal cancer screening strategies[J].Nat Rev Gastroenterol Hepatol,2022,19(8):521-531.
19 Chen YJ,Roumeliotis TI,Chang YH,et al.Proteogenomics of non-smoking lung cancer in East Asia delineates molecular signatures of pathogenesis and progression[J].Cell,2020,182(1):226-244.
20 Lancaster HL,Heuvelmans MA,Oudkerk M.Low-dose computed tomography lung cancer screening:clinical evidence and implementation research[J].J Intern Med,2022,292(1):68-80.

[1]	柴莉莉, 李伟伟, 董建梅, 秦绪成, 张伟伟, 相璐, 仲玮, 王威, 马昭君. 2008—2019年连云港市食管癌发病与死亡情况及趋势分析[J]. 实用肿瘤学杂志, 2025, 39(2): 80-85.
[2]	吴宜伟, 韩静, 颜雪, 王文瑞. 内蒙古自治区2010—2020年头颈部肿瘤死亡趋势分析[J]. 实用肿瘤学杂志, 2025, 39(2): 86-90.
[3]	文小焱, 陈俐. 2010年和2020年四川省30岁及以上人群恶性肿瘤疾病负担比较分析[J]. 实用肿瘤学杂志, 2025, 39(1): 1-6.
[4]	寇帅, 王榆平, 孙小霞, 任娟娟. 基于年龄-时期-队列模型的1992—2021年中国卵巢癌发病和死亡分析[J]. 实用肿瘤学杂志, 2025, 39(1): 7-12.
[5]	陈茂森, 文洪梅, 石青萍, 邵英, 唐娴, 任思颖, 陈杨. 2020年云南省肿瘤登记地区宫颈癌发病和死亡情况及2012—2020年趋势分析[J]. 实用肿瘤学杂志, 2024, 38(6): 355-360.
[6]	王梅仙, 郑克勤, 余秋丽, 文洪梅, 杨沧江, 任思颖. 云南省2020年食管癌发病和死亡情况及2012—2020年趋势分析[J]. 实用肿瘤学杂志, 2024, 38(6): 361-366.
[7]	徐仙会, 陈杨, 朱云芳, 李明松, 文洪梅. 2020年云南省肿瘤登记地区肺癌发病和死亡情况及2012—2020年趋势分析[J]. 实用肿瘤学杂志, 2024, 38(6): 367-371.
[8]	孔虹倩, 董娟, 文洪梅, 邵英, 成会荣, 余秋丽. 云南省肿瘤登记地区2020年胃癌发病和死亡情况及2012—2020年趋势分析[J]. 实用肿瘤学杂志, 2024, 38(6): 372-376.
[9]	董娟, 孔虹倩, 文洪梅, 石青萍, 邵英. 云南省肿瘤登记地区2020年前列腺癌发病和死亡情况及2012—2020年趋势分析[J]. 实用肿瘤学杂志, 2024, 38(6): 383-387.
[10]	陈茂森, 陈杨, 石青萍, 邵英, 唐娴, 任思颖, 文洪梅. 2020年云南省恶性肿瘤发病和死亡分析[J]. 实用肿瘤学杂志, 2024, 38(5): 283-288.
[11]	赵倩雯, 佘欣, 耿利军, 彭丹莉, 刘姗姗. 1990—2021年中国胃癌发病趋势的年龄-时期-队列[J]. 实用肿瘤学杂志, 2024, 38(5): 289-294.
[12]	苏锋, 梁磊, 邓英, 张同蕾, 王艳平. 2016—2020年陕西省安康市恶性肿瘤流行特征和变化趋势分析[J]. 实用肿瘤学杂志, 2024, 38(5): 300-305.
[13]	何佳颖, 朱津丽, 贾凯旋, 杨佩颖. IFN-γ在肿瘤免疫检查点抑制剂治疗中的研究进展[J]. 实用肿瘤学杂志, 2024, 38(5): 330-335.
[14]	马娜, 刘捷. 天津市河东区2015—2020年肺癌发病与死亡情况分析[J]. 实用肿瘤学杂志, 2024, 38(4): 241-245.
[15]	刘丽莉, 张雪云, 张雷. 2020—2022年第一师阿拉尔市恶性肿瘤发病分析[J]. 实用肿瘤学杂志, 2024, 38(4): 246-253.

2020年云南省昆明市肿瘤登记地区恶性肿瘤发病和死亡特征及2016—2020年趋势分析

Analyses for the incidence and mortality characteristics of malignant tumors in the cancer registration areas of Kunming City,Yunnan Province in 2020 and their trend from 2016 to 2020

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价